Income Taxes - Additional Information (Details) - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Income Tax Disclosure [Line Items]
Deferred tax assets related to capitalized research expenses, increase	$ 105,000,000	$ 82,000,000
Valuation allowance	$ 0	$ 0
Federal statutory income tax rate	21.00%	21.00%
Permanent differences by disallowance of certain executive compensation minimum amount	$ 1,000,000	$ 1,000,000
Penalties and interest related to uncertain tax positions	4,800,000
Unrecognized tax benefits that would impact tax rate	900,000	700,000
Unrecognized tax benefits expected to reverse	9,500,000
Unrecognized tax positions, interest	600,000	0
Unrecognized tax positions, penalties	4,000,000	0
Unrecognized tax benefits	38,899,000	716,000	$ 2,269,000
Tax benefit on annual limitation on deductibility of executive compensation		400,000
Impermissible Method in Deducting Stock-Based Compensation Expense for Income Tax Purposes
Income Tax Disclosure [Line Items]
Unrecognized tax benefits		1,900,000
R&D Credits
Income Tax Disclosure [Line Items]
Penalties and interest related to uncertain tax positions	4,600,000
Unrecognized tax benefits	600,000	400,000
IRC Section 174 Research And Development
Income Tax Disclosure [Line Items]
Unrecognized tax benefits	$ 38,000,000	$ 14,500,000